Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes.
Clin Pharmacol Ther. 1998 May;63(5):519-28. doi: 10.1016/S0009-9236(98)90103-5.
Clin Pharmacol Ther. 1998.
PMID: 9630825
Clinical Trial.
Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes.
Takahashi H, Kashima T, Nomoto S, Iwade K, Tainaka H, Shimizu T, Nomizo Y, Muramoto N, Kimura S, Echizen H.
Takahashi H, et al. Among authors: nomizo y.
Pharmacogenetics. 1998 Oct;8(5):365-73. doi: 10.1097/00008571-199810000-00001.
Pharmacogenetics. 1998.
PMID: 9825828
Item in Clipboard
Effect of buthionine sulphoximine, glutathione and methimazole on the renal disposition of cisplatin and on cisplatin-induced nephrotoxicity in rats: pharmacokinetic-toxicodynamic analysis.
Hanada K, Mukasa Y, Nomizo Y, Ogata H.
Hanada K, et al. Among authors: nomizo y.
J Pharm Pharmacol. 2000 Dec;52(12):1483-90. doi: 10.1211/0022357001777694.
J Pharm Pharmacol. 2000.
PMID: 11197076
Item in Clipboard
Cite
Cite